GI
BMY icon

GAMCO Investors’s Bristol-Myers Squibb BMY Stock Holding History

GAMCO Investors’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-100
Closed -$152K – 931
2019
Q1 		$152K Buy
+100
New +$4.98K ﹤0.01% 823

Other funds holding BMY

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

GAMCO Investors's BMY Position: Q1 2026 in Review

GAMCO Investors reduced its Bristol-Myers Squibb (BMY) stake by 7.8% in Q1 2026, selling an estimated $430K and leaving 87,058 shares worth $5.28M. The position accounts for 0.05% of the portfolio, ranked #350.

GAMCO Investors first reported a position in BMY in Q2 2013 and has held it in 52 quarters since. The position peaked at $45.6M in Q2 2016. 2,519 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

  • GAMCO Investors held 87,058 shares of Bristol-Myers Squibb worth $5.28M as of Q1 2026.
  • GAMCO Investors sold 7,380 Bristol-Myers Squibb shares in Q1 2026, an estimated $430K.
  • Bristol-Myers Squibb made up 0.05% of GAMCO Investors's portfolio in Q1 2026, its #350 holding.
  • GAMCO Investors first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 52 quarters since.
  • GAMCO Investors's Bristol-Myers Squibb position peaked at $45.6M in Q2 2016.
  • 2,519 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on GAMCO Investors's 13F filing for Q1 2026, filed 14 May 2026.